![](https://ml.globenewswire.com/media/7de60592-5292-47db-b269-9fb31fb51a2d/small/ziopharm-rgb-hires-1-jpg.jpg)
Ziopharm Comments on Delay of WaterMill’s Stated Consent Deadline
Ziopharm Recommends Shareholders Return the GREEN Consent Revocation Card BOSTON, Dec. 11, 2020 (GLOBE NEWSWIRE) -- Ziopharm Oncology, Inc. (Nasdaq: ZIOP) (“Ziopharm” or the “Company”), today issued a statement in connection with the consent solicitation ( …